600566 濟川藥業
按盤價 
26.700 +0.050 (+0.188%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.167 | 18.049 | 22.869 | 21.226 | 20.369 |
| 總資產報酬率 ROA (%) | 5.844 | 13.832 | 17.043 | 16.013 | 15.182 |
| 投入資產回報率 ROIC (%) | 6.659 | 16.387 | 20.822 | 19.532 | 18.433 | 邊際利潤分析 |
| 銷售毛利率 (%) | 76.282 | 79.250 | 81.522 | 82.911 | 83.270 |
| 營業利潤率 (%) | 31.920 | 35.711 | 33.747 | 26.939 | 25.330 |
| 息稅前利潤/營業總收入 (%) | 30.666 | 34.146 | 31.484 | 26.924 | 24.395 |
| 淨利潤/營業總收入 (%) | 26.045 | 31.642 | 29.282 | 24.140 | 22.505 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 82.865 | 88.248 | 95.177 | 94.725 | 90.637 |
| 價值變動淨收益/利潤總額(%) | 13.818 | 6.136 | 2.922 | 2.348 | 8.282 |
| 營業外收支淨額/利潤總額(%) | 0.419 | 3.873 | 1.181 | 3.366 | 0.903 | 償債能力分析 |
| 流動比率 (X) | 5.324 | 4.155 | 3.100 | 3.261 | 2.900 |
| 速動比率 (X) | 5.182 | 3.994 | 2.993 | 3.147 | 2.766 |
| 資產負債率 (%) | 16.184 | 20.223 | 26.317 | 24.222 | 24.730 |
| 帶息債務/全部投入資本 (%) | 5.031 | 6.482 | 9.595 | 4.995 | 7.595 |
| 股東權益/帶息債務 (%) | 1,859.700 | 1,423.752 | 929.452 | 1,868.877 | 1,190.599 |
| 股東權益/負債合計 (%) | 516.839 | 393.828 | 279.579 | 312.426 | 303.897 |
| 利息保障倍數 (X) | -22.079 | -11.367 | -11.805 | -28.242 | -20.923 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 127.822 | 110.015 | 103.627 | 98.903 | 95.507 |
| 存貨周轉天數 (天) | 132.282 | 114.605 | 88.946 | 89.808 | 92.218 |
| 備註： | 即時報價更新時間為 26/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
